BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed TARS catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:9d327d10c55f22cffc2e@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:TARS P2 readout (est.): Study of Lotilaner Ophthalmic Gel in Patien
 ts With Ocular Rosacea (KORE)
DESCRIPTION:Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosac
 ea (KORE)\nNCT07443202 | PHASE2 | ENROLLING_BY_INVITATION | sponsor: Tarsu
 s Pharmaceuticals\, Inc.\nPrimary completion date (ESTIMATED)\; top-line r
 esults usually follow later.\nTicker TARS (confidence 0.9)\nSource: https:
 //clinicaltrials.gov/study/NCT07443202\nScheduling/reference data from pub
 lic records\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT07443202
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
